Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 52,744Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1MSN Laboratories Private Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for 1254053-84-3 / Gilteritinib Fumarate API manufacturers, exporters & distributors?

Gilteritinib Fumarate manufacturers, exporters & distributors 1

72

PharmaCompass offers a list of Gilteritinib Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gilteritinib Fumarate manufacturer or Gilteritinib Fumarate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gilteritinib Fumarate manufacturer or Gilteritinib Fumarate supplier.

PharmaCompass also assists you with knowing the Gilteritinib Fumarate API Price utilized in the formulation of products. Gilteritinib Fumarate API Price is not always fixed or binding as the Gilteritinib Fumarate Price is obtained through a variety of data sources. The Gilteritinib Fumarate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Gilteritinib Fumarate

Synonyms

Gilteritinib hemifumarate, Asp-2215 hemifumarate, 1254053-84-3, Gilteritinib fumarate [usan], Asp2215 hemifumarate, 5rzz0z1gjt

Cas Number

1254053-84-3

Unique Ingredient Identifier (UNII)

5RZZ0Z1GJT

About Gilteritinib Fumarate

Gilteritinib Fumarate is the fumarate salt form of gilteritinib, an orally bioavailable inhibitor of the receptor tyrosine kinases (RTKs) FMS-like tyrosine kinase 3 (FLT3; STK1; FLK2), AXL (UFO; JTK11), anaplastic lymphoma kinase (ALK; CD246), and leukocyte receptor tyrosine kinase (LTK), with potential antineoplastic activity. Upon administration, gilteritinib binds to and inhibits both the wild-type and mutated forms of FLT3, AXL, ALK and LTK. This may result in an inhibition of FLT3-, AXL-, ALK-, and LTK-mediated signal transduction pathways and reduced proliferation in cancer cells that overexpress these RTKs. FLT3, AXL, ALK, and LTK, which are overexpressed or mutated in a variety of cancer cell types, play key roles in tumor cell growth and survival.

1254053-84-3 Manufacturers

A 1254053-84-3 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1254053-84-3, including repackagers and relabelers. The FDA regulates 1254053-84-3 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1254053-84-3 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 1254053-84-3 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

1254053-84-3 Suppliers

A 1254053-84-3 supplier is an individual or a company that provides 1254053-84-3 active pharmaceutical ingredient (API) or 1254053-84-3 finished formulations upon request. The 1254053-84-3 suppliers may include 1254053-84-3 API manufacturers, exporters, distributors and traders.

click here to find a list of 1254053-84-3 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

1254053-84-3 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1254053-84-3 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for 1254053-84-3 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture 1254053-84-3 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain 1254053-84-3 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1254053-84-3 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of 1254053-84-3 suppliers with NDC on PharmaCompass.

1254053-84-3 Manufacturers | Traders | Suppliers

1254053-84-3 Manufacturers, Traders, Suppliers 1
46

We have 1 companies offering 1254053-84-3

Get in contact with the supplier of your choice:

  1. MSN Laboratories
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.